Home
Aurobindo Pharma USA

Aurobindo Pharma USA Market Share Analysis for March 2026

Our Products

Health > Biotechnology and Pharmaceuticals

Domainaurobindousa.com

Year Founded1992

Employees501 - 1000

Annual Revenue$50M - $75M

Aurobindo Pharma USA

Aurobindo Pharma USA (including company regionals)

aurobindousa.com

See more website traffic and engagement information

Aurobindo Pharma USA Revenue up to March 2026 is 50M - 75M

revenue generated by Aurobindo Pharma USA top domains

Aurobindo Pharma USA top domains revenue over 3 years

Revenue for Aurobindo Pharma USA top domains

aurobindousa.com50M - 75M

See more with Sales Intelligence

Total visits to Aurobindo Pharma USA's top domains

Understand Aurobindo Pharma USA market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

aurobindousa.com10.9K

See more with Sales Intelligence

Avg. visit duration in Aurobindo Pharma USA's top domains

Analyze Aurobindo Pharma USA engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

aurobindousa.com00:00:21

See more with Sales Intelligence

Avg. pageviews on Aurobindo Pharma USA's top domains

See how Aurobindo Pharma USA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

aurobindousa.com1.62

See more with Sales Intelligence

Aurobindo Pharma USA top competitors by domain

Top similar sites in March 2026, ranked by their affinity

aurobindo.comCompany NameAurobindo Pharma LimitedEmployees> 10001HQIndia, HyderabadAnnual revenue$25M - $50MTotal visits25KHealth > Health - Other

Top technologies used by Aurobindo Pharma USA

These are the website technologies, by industry, used by Aurobindo Pharma USA top domains

Payment & Currencies (9)

Cart Functionality

Widget (5)

Twemoji

Advertising (3)

DoubleClick

eCommerce (3)

WooCommerce

More Technologies

11

See all

News & Signals from Aurobindo Pharma USA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAurobindo Pharma USA, Inc. launches Metformin Hydrochloride Extended-Release Tablets.Previously, Aurobindo has launched other diabetes medications in the U.S., such as Metformin Hydrochloride Extended-Release Tablets in 2012 and Saxagliptin Tablets in 2023.

NewsKhandelwal Laboratories PVT. LTD sold assets to Aurobindo Pharma USA, Inc. on Jan 1st '26.Aurobindo Pharma on Thursday announced that its subsidiary, Auro Pharma, will acquire the non-oncology prescription formulations business of Khandelwal Laboratories on a going concern basis through a slump sale.